<SEC-DOCUMENT>0001193125-23-269437-index.html : 20231102
<SEC-HEADER>0001193125-23-269437.hdr.sgml : 20231102
<ACCEPTANCE-DATETIME>20231102164120
ACCESSION NUMBER:		0001193125-23-269437
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20231102
DATE AS OF CHANGE:		20231102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allogene Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001737287
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				823562771
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268117
		FILM NUMBER:		231373117

	BUSINESS ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 457-2700

	MAIL ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d553370d424b5.htm
<DESCRIPTION>424B5
<TEXT>
Document 1 - file: d553370d424b5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>d553370dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 2 - file: d553370dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g553370g09c84.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: g553370g09c84.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g553370g53b65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g553370g53b65.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g553370g79m67.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g553370g79m67.jpg

</DOCUMENT>
</SEC-DOCUMENT>